CoChat

Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Côte d'Ivoire: a two-arm, cluster-randomised controlled trial

Open access

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index; 26 of the 32 sources its claims cite were checked for support.

Abstract

BACKGROUND: New vector control tools are required to sustain the fight against malaria. Lethal house lures, which target mosquitoes as they attempt to enter houses to blood feed, are one approach. Here we evaluated lethal house lures consisting of In2Care (Wageningen, Netherlands) Eave Tubes, which provide point-source insecticide treatments against host-seeking mosquitoes, in combination with house screening, which aims to reduce mosquito entry. METHODS: We did a two-arm, cluster-randomised controlled trial with 40 village-level clusters in central Côte d'Ivoire between Sept 26, 2016, and April 10, 2019. All households received new insecticide-treated nets at universal coverage (one bednet per two people). Suitable households within the clusters assigned to the treatment group were offered screening plus Eave Tubes, with Eave Tubes treated using a 10% wettable powder formulation of the pyrethroid β-cyfluthrin. Because of the nature of the intervention, treatment could not be masked for households and field teams, but all analyses were blinded. The primary endpoint was clinical malaria incidence recorded by active case detection over 2 years in cohorts of children aged 6 months to 10 years. This trial is registered with ISRCTN, ISRCTN18145556. FINDINGS: 3022 houses received screening plus Eave Tubes, with an average coverage of 70% across the intervention clusters. 1300 eligible children were recruited for active case detection in the control group and 1260 in the intervention group. During the 2-year follow-up period, malaria case incidence was 2·29 per child-year (95% CI 1·97-2·61) in the control group and 1·43 per child-year (1·21-1·65) in the intervention group (hazard ratio 0·62, 95% CI 0·51-0·76; p<0·0001). Cost-effectiveness simulations suggested that screening plus Eave Tubes has a 74·0% chance of representing a cost-effective intervention, compared with existing healthcare activities in Côte d'Ivoire, and is similarly cost-effective to other core vector control interventions across sub-Saharan Africa. No serious adverse events associated with the intervention were reported during follow-up. INTERPRETATION: Screening plus Eave Tubes can provide protection against malaria in addition to the effects of insecticide-treated nets, offering potential for a new, cost-effective strategy to supplement existing vector control tools. Additional trials are needed to confirm these initial results and further optimise Eave Tubes and the lethal house lure concept to facilitate adoption. FUNDING: The Bill & Melinda Gates Foundation.

Overview

CoChat Summary

TL;DR

In a 40-cluster randomized trial in central Côte d'Ivoire, screening plus Eave Tubes plus insecticide-treated nets reduced clinical malaria incidence in children versus nets alone (HR 0.62). The intervention also reduced mosquito density and entomological inoculation rates, and cost-effectiveness simulations suggested a 74.0% chance of being cost-effective in Côte d'Ivoire.

Key findings

  • Clinical malaria incidence over 2 years was 2.29 per child-year in the control group versus 1.43 per child-year in the intervention group (HR 0.62, 95% CI 0.51–0.76; p<0.0001).
  • Mean indoor mosquito density was 24.7 in controls versus 13.0 in the intervention group (density ratio 0.39, 95% CI 0.20–0.74; p=0.0040); indoor annual EIR was 170 versus 53 infectious bites per person (RR 0.28, 95% CI 0.16–0.50; p<0.0001). Outdoor EIR was 165 versus 61 (RR 0.33, 95% CI 0.19–0.57; p<0.0001).
  • The intervention was estimated to have a 74.0% chance of being cost-effective in Côte d'Ivoire. Median cost-effectiveness estimates were US$28.91 per malaria case averted and US$210.29 per DALY averted from the societal perspective, and $26.44 and $192.30 respectively from the provider perspective.
  • No serious adverse events associated with the intervention were reported; during follow-up, 12 children died (9 control, 3 intervention), and 5 deaths were due to malaria (3 control, 2 intervention).

Methods

  • Two-arm, cluster-randomised controlled trial with 40 village-level clusters in central Côte d'Ivoire (20 per group), conducted Sept 26, 2016 to Apr 10, 2019, with universal distribution of insecticide-treated nets in both groups.
  • Intervention: house screening plus In2Care Eave Tubes treated with 10% wettable powder β-cyfluthrin; primary endpoint was clinical malaria incidence in cohorts of children aged 6 months to 10 years, with entomological and economic outcomes also measured.
  • Main analyses used Cox proportional hazards models for malaria incidence, mixed-effects logistic models for anaemia, and negative binomial mixed-effects models for mosquito density and EIR; cost-effectiveness was estimated by simulation using trial costs and incidence differences.

Limitations

  • The paper states that additional trials are needed to confirm the results and further optimize Eave Tubes and the lethal house lure concept.
  • The coverage/dose-response analysis was not in the analysis plan and the trial was not powered for it, so those findings “should be treated with caution” (stated in the paper).
  • Evident from the text: households and field teams could not be masked because the intervention was visible, although analyses were blinded.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(21)00250-6

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 A house in Côte d'Ivoire with screening plus Eave Tubes The inset shows the Eave Tube insert placed within the tube.
Figure 1 A house in Côte d'Ivoire with screening plus Eave Tubes The inset shows the Eave Tube insert placed within the tube.CC BY · PubMed Central
Figure 2 Timeline of study activities
Figure 2 Timeline of study activitiesCC BY · PubMed Central
Figure 3 Study profile
Figure 3 Study profileCC BY · PubMed Central
Figure 4 Cluster-level malaria case incidence by month for the 2-year follow-up Open circles show cluster-level malaria case incidence, and closed diamonds show the mean of the cluster incidences, with bars representing 95% CIs.
Figure 4 Cluster-level malaria case incidence by month for the 2-year follow-up Open circles show cluster-level malaria case incidence, and closed diamonds show the mean of the cluster incidences, with bars representing 95% CIs.CC BY · PubMed Central
Figure 5 Association between SET coverage and malaria case incidence Each circle represents a cluster. SET=screening plus Eave Tubes.
Figure 5 Association between SET coverage and malaria case incidence Each circle represents a cluster. SET=screening plus Eave Tubes.CC BY · PubMed Central

Verification

Claims the paper makes

13 Valid · 0 Not valid · 9 Not checked · 72 Own results and interpretations

41 more claims · 2 with their cited sources checked

Create a free account to see all 94 claims and to verify the 6 references still open.

See all claims — free account
  • Probably not a substantial claim. 24
  • It may state two separate claims as one. 31
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

1 of 1

Citations

Cites

Show all 29 references

Cited by

See all 58

Metadata

Authors
Sternberg, E. D., Cook, J., Alou, L. P. A., Assi, S. B., Koffi, A. A., Doudou, D. T., Aoura, C. J., Wolie, R. Z., Oumbouke, W. A., Worrall, E., Kleinschmidt, I., N'Guessan, R., & Thomas, M. B.
Affiliations
  • Pennsylvania State University (US)
  • London School of Hygiene & Tropical Medicine (GB)
  • Institut National de Santé Publique (CI)
  • Université Alassane Ouattara (CI)
  • Liverpool School of Tropical Medicine (GB)
  • University of the Witwatersrand (ZA)
Corresponding author
Sternberg, Eleanore D
Venue
The Lancet
Publisher
Elsevier BV
Published
2021-02
Volume
397
Issue
10276
Pages
805-815
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W3133887945
Cited by
57
References
29
Citations by year
2026: 4 · 2025: 12 · 2024: 13 · 2023: 10 · 2022: 8 · 2021: 10
FWCI
9.26
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
Funders
Bill and Melinda Gates Foundation
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Insect Pest Control Strategies
Keywords
malaria vector control, house screening, beta-cyfluthrin, pyrethroid insecticides, host-seeking mosquitoes, clinical malaria incidence, children under 10, cost-effectiveness, insecticide-treated nets, Côte d'Ivoire, sub-Saharan Africa, malaria elimination, active case finding, adverse events
MeSH terms
Animals, Child, Child, Preschool, Cost-Benefit Analysis, Female, Humans, Infant, Cote d'Ivoire, Malaria, Male, Mosquito Control, Pyrethrins, Insecticide-Treated Bednets

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Côte d'Ivoire: a two-arm, cluster-randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(21)00250-6
The paper
Sternberg, E. D., Cook, J., Alou, L. P. A., Assi, S. B., Koffi, A. A., Doudou, D. T., Aoura, C. J., Wolie, R. Z., Oumbouke, W. A., Worrall, E., Kleinschmidt, I., N'Guessan, R., & Thomas, M. B. (2021). Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Côte d'Ivoire: a two-arm, cluster-randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(21)00250-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.